A panel of journalists joins Diane for analysis of the week's top international news stories.
A panel talks about changes in how drugs are marketed, from direct-to-consumer ads to patient education and support groups funded by pharmaceutical companies.
- Dr. Thomas Murray fellow at the Hastings Center
- Dr. Michael Shaw executive director of EthicAd, a nonprofit group formed to create standards for direct-to-consumer drug ads
- Mary Nell Lenhard senior vice president for policy and representation at the Blue Cross Blue Shield Association
- Dr. Adrian Di Bisceglie medical director of the American Liver Foundation and professor of internal medicine at St. Louis University
Most Recent Shows
A panel of journalists joins Diane for analysis of the week's top national news stories.
The National Endowment for the Humanities turns 50 next year. William “Bro” Adams, the new chairman of the National Endowment for the Humanities, wants to make sure that the study of history, philosophy, and literature remains accessible to everyone. A conversation about his new "Common Good" initiative.
The Cystic Fibrosis Foundation is earning more than $3 billion from its investment in a new drug. Other charitable organizations are hoping to follow a similar path. New opportunities and new questions for nonprofits.